(18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer

To evaluate (18)F-labeled-fluorodeoxyglucose ((18)F-FDG-) and (18)F-labeled-sodium fluoride ((18)F-NaF-) positron emission tomography/computed tomography (PET/CT) as biomarkers in metastatic castrate-resistant prostate cancer (mCRPC). Nine men (53-75 years) in a phase 1 trial of abiraterone and cabo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Nucl Med Mol Imaging
Main Authors: Zukotynski, Katherine A, Kim, Chun K, Gerbaudo, Victor H, Hainer, Jon, Taplin, Mary-Ellen, Kantoff, Philip, den Abbeele, Annick D Van, Seltzer, Steven, Sweeney, Christopher J
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2014
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4299771/
https://ncbi.nlm.nih.gov/pubmed/25625029
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki